| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | France | 3 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | Republic of Korea | 1 | |
| #7 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Gobron Stephane | 10 |
| #2 | Bridon Dominique | 8 |
| #3 | Gobron Stéphane | 6 |
| #4 | Lalloue Fabrice | 4 |
| #5 | Bibes Romain | 4 |
| #6 | Cabart Frédéric | 2 |
| #7 | Fauster Christian | 2 |
| #8 | Vincent François | 2 |
| #9 | Vincent Francois | 2 |
| #10 | Meiniel Annie | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP3360884A1 | Improved process for the preparation of a dodecapeptide | |
| WO2017051135A1 | Cyclic polypeptides, method for obtaining said polypeptides and the therapeutic use thereof | |
| FR3024364A1 | PARTICULATE OLIGOPEPTIDES AS ANTI-ANGIOGENIC DRUGS | |
| FR2910003A1 | Novel peptides and polypeptides with improved stability useful in regeneration of the nervous system |